Amturnide Approval History 
- FDA approved: Yes (First approved December 21st, 2010)
- Brand name: Amturnide
- Generic name: aliskiren, amlodipine and hydrochlorothiazide
- Company: Novartis Pharmaceuticals Corporation
- Treatment for: High Blood Pressure
Amturnide (aliskiren, amlodipine and hydrochlorothiazide) is a direct renin inhibitor, calcium channel blocker and diuretic combination for the treatment of high blood pressure.
FDA Approval History for Amturnide
| Date | Article |
|---|---|
| Dec 22, 2010 |  Novartis Gains FDA Approval for Amturnide, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications |
See also...
Amturnide (aliskiren, amlodipine and hydrochlorothiazide) Consumer Information
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
